RESEARCH PAPER
Cigarette Smoking and the Risk of Bladder Cancer in Men and Women
 
More details
Hide details
1
Department of Biology and Health Services, Edinboro University of Pennsylvania, Edinboro, Pennsylvania, USA
 
2
Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York, USA
 
3
Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA
 
 
Publication date: 2004-09-15
 
 
Tobacco Induced Diseases 2004;2(September):141
 
KEYWORDS
ABSTRACT
Although cigarette smoking is a principal risk factor for bladder cancer in both men and women, few studies have statistically evaluated whether gender modifies the effect of smoking on bladder cancer risk. We initiated the present case-control study at Roswell Park Cancer Institute in Buffalo, New York, U.S., to provide further data on this important issue. We observed similar risk estimates for men and women with comparable smoking exposures, but did not observe a statistically significant interaction between gender and lifetime smoking exposure. We conclude that cigarette smoking is a major risk factor for bladder cancer in both sexes, but that gender does not modify the effect of smoking on bladder cancer risk.
 
REFERENCES (13)
1.
Silverman DT, Morrison AS, Devesa SS: Bladder cancer. Cancer Epidemiology and Prevention. Edited by: Schottenfeld D, Fraumeni JF Jr. 1996, Oxford University Press, New York, 1156-1179. 2.
 
2.
Negri E, La Vecchia C: Epidemiology and prevention of bladder cancer. European Journal of Cancer Prevention. 2001, 10: 7-14. 10.1097/00008469-200102000-00002.
 
3.
Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC: Gender- and smoking-related bladder cancer risk. Journal of the National Cancer Institute. 2001, 93: 538-545. 10.1093/jnci/93.7.538.
 
4.
Mettlin C: Milk drinking, other beverage habits, and lung cancer risk. International Journal of Cancer. 1989, 43: 608-612. 10.1002/ijc.2910430412.
 
5.
Jung I, Messing E: Molecular mechanisms and pathways in bladder cancer development and progression. Cancer Control. 2000, 7: 325-334.
 
6.
Thompson WD: Effect modification and the limits of biological inference from epidemiologic data. Journal of Clinical Epidemiology. 1991, 44: 221-232. 10.1016/0895-4356(91)90033-6.
 
7.
Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, Miller AB: Risk of bladder cancer by source and type of tobacco exposure: a case-control study. International Journal of Cancer. 1989, 44: 622-628. 10.1002/ijc.2910440411.
 
8.
Augustine A, Hebert JR, Kabat GC, Wynder EL: Bladder cancer in relation to cigarette smoking. Cancer Research. 1988, 48: 4405-4408.
 
9.
Hartge P, Harvey EB, Linehan WM, Silverman DT, Sullivan JW, Hoover RN, Fraumeni JF: Unexplained excess risk of bladder cancer in men. Journal of the National Cancer Institute. 1990, 82: 1636-1640. 10.1093/jnci/82.20.1636.
 
10.
Chiu BC, Lynch CF, Cerhan JP, Cantor KP: Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Annals of Epidemiology. 2001, 11: 28-37. 10.1016/S1047-2797(00)00175-7.
 
11.
Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, T'Mannetje A, Kogevinas M, Boffetta P: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. International Journal of Cancer. 2000, 86: 289-294. 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M.
 
12.
Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jockel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P: The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes and Control. 2001, 12: 411-417. 10.1023/A:1011214222810.
 
13.
Madeb R, Messing EM: Gender, racial and age differences in bladder cancer incidence and mortality. Urologic Oncology. 2004, 22: 86-92.
 
 
CITATIONS (5):
1.
Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis
Jie Xiong, Ke Xiong, Zhitong Bing
Cancer Biomarkers
 
2.
Bladder cancer incidence among workers exposed too-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant
Tania Carreón, Misty J Hein, Kevin W Hanley, Susan M Viet, Avima M Ruder
Occupational and Environmental Medicine
 
3.
Histopathological Evaluation of Urothelial Carcinomas in Transurethral Resection Urinary Bladder Tumor Specimens: Eight Years of Single Center Experience
Ali Koyuncuer
Asian Pacific Journal of Cancer Prevention
 
4.
Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer
Osch van, Jelle Vlaanderen, Sylvia Jochems, Cristina Bosetti, Jerry Polesel, Stefano Porru, Angela Carta, Klaus Golka, Xuejuan Jiang, Mariana Stern, Wei-De Zhong, Eliane Kellen, Hermann Pohlabeln, Li Tang, James Marshall, Gunnar Steineck, Margaret Karagas, Kenneth Johnson, Zuo-Feng Zhang, Jack Taylor, Vecchia La, Richard Bryan, Schooten van, Anke Wesselius, Maurice Zeegers
Epidemiology
 
5.
CLINICOPATHOLOGICAL ANALYSIS OF OVARIAN TUMOURS IN A TERTIARY CARE INSTITUTE AND THE ROLE OF ER, PR AND HER-2/neu IN SURFACE EPITHELIAL TUMOURS OF OVARY
Thangaraj Priya, Alagappan Santhi
Journal of Evolution of Medical and Dental Sciences
 
eISSN:1617-9625
Journals System - logo
Scroll to top